Chlorine in PDB 1aid: Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease: Developing A Cycle of Structure-Based Drug Design
Enzymatic activity of Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease: Developing A Cycle of Structure-Based Drug Design
All present enzymatic activity of Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease: Developing A Cycle of Structure-Based Drug Design:
3.4.23.16;
Protein crystallography data
The structure of Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease: Developing A Cycle of Structure-Based Drug Design, PDB code: 1aid
was solved by
E.E.Rutenber,
E.B.Fauman,
R.J.Keenan,
R.M.Stroud,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
7.00 /
2.20
|
Space group
|
P 41
|
Cell size a, b, c (Å), α, β, γ (°)
|
50.200,
50.200,
100.400,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
17.4 /
n/a
|
Other elements in 1aid:
The structure of Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease: Developing A Cycle of Structure-Based Drug Design also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease: Developing A Cycle of Structure-Based Drug Design
(pdb code 1aid). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease: Developing A Cycle of Structure-Based Drug Design, PDB code: 1aid:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 1aid
Go back to
Chlorine Binding Sites List in 1aid
Chlorine binding site 1 out
of 4 in the Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease: Developing A Cycle of Structure-Based Drug Design
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease: Developing A Cycle of Structure-Based Drug Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl203
b:23.0
occ:0.50
|
CL
|
B:CL203
|
0.0
|
23.0
|
0.5
|
CL
|
B:CL203
|
1.3
|
23.0
|
0.5
|
N
|
B:ILE50
|
3.0
|
26.7
|
0.5
|
N
|
A:ILE50
|
3.1
|
27.3
|
0.5
|
N1
|
B:THK201
|
3.1
|
76.7
|
0.5
|
CA
|
A:GLY49
|
3.1
|
33.9
|
0.5
|
C6
|
B:THK201
|
3.1
|
77.6
|
0.5
|
N1
|
B:THK201
|
3.3
|
76.6
|
0.5
|
C5
|
B:THK201
|
3.3
|
72.9
|
0.5
|
C6
|
B:THK201
|
3.4
|
77.7
|
0.5
|
C5
|
B:THK201
|
3.5
|
72.9
|
0.5
|
CG1
|
B:ILE50
|
3.5
|
22.9
|
0.5
|
C
|
A:GLY49
|
3.7
|
33.8
|
0.5
|
CA
|
B:GLY49
|
3.7
|
21.3
|
0.5
|
CB
|
A:ILE50
|
3.7
|
24.8
|
0.5
|
CB
|
B:ILE50
|
3.8
|
20.7
|
0.5
|
C
|
B:GLY49
|
3.8
|
27.2
|
0.5
|
C2
|
B:THK201
|
3.9
|
76.6
|
0.5
|
C7
|
B:THK201
|
4.0
|
75.4
|
0.5
|
C3
|
B:THK201
|
4.0
|
70.0
|
0.5
|
C7
|
B:THK201
|
4.0
|
75.4
|
0.5
|
CA
|
B:ILE50
|
4.0
|
25.0
|
0.5
|
CA
|
A:ILE50
|
4.1
|
24.3
|
0.5
|
CD1
|
A:ILE50
|
4.2
|
20.7
|
0.5
|
CD1
|
B:ILE50
|
4.2
|
28.2
|
0.5
|
C8
|
B:THK201
|
4.3
|
76.2
|
0.5
|
C4
|
B:THK201
|
4.4
|
73.0
|
0.5
|
N
|
A:GLY49
|
4.4
|
34.1
|
0.5
|
CG1
|
A:ILE50
|
4.4
|
26.0
|
0.5
|
C2
|
B:THK201
|
4.4
|
76.6
|
0.5
|
C4
|
B:THK201
|
4.5
|
73.0
|
0.5
|
C3
|
B:THK201
|
4.5
|
70.0
|
0.5
|
C8
|
B:THK201
|
4.6
|
76.2
|
0.5
|
O
|
A:GLY48
|
4.7
|
45.7
|
1.0
|
CG2
|
A:ILE50
|
4.8
|
26.2
|
0.5
|
O
|
A:GLY49
|
4.9
|
39.6
|
0.5
|
C
|
A:GLY48
|
4.9
|
40.0
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 1aid
Go back to
Chlorine Binding Sites List in 1aid
Chlorine binding site 2 out
of 4 in the Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease: Developing A Cycle of Structure-Based Drug Design
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease: Developing A Cycle of Structure-Based Drug Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl203
b:23.0
occ:0.50
|
CL
|
B:CL203
|
0.0
|
23.0
|
0.5
|
CL
|
B:CL203
|
1.3
|
23.0
|
0.5
|
N
|
B:ILE50
|
2.3
|
26.7
|
0.5
|
CA
|
B:GLY49
|
2.7
|
21.3
|
0.5
|
C
|
B:GLY49
|
2.8
|
27.2
|
0.5
|
N1
|
B:THK201
|
3.1
|
76.6
|
0.5
|
C6
|
B:THK201
|
3.1
|
77.7
|
0.5
|
N1
|
B:THK201
|
3.3
|
76.7
|
0.5
|
C5
|
B:THK201
|
3.3
|
72.9
|
0.5
|
CG1
|
B:ILE50
|
3.3
|
22.9
|
0.5
|
C6
|
B:THK201
|
3.4
|
77.6
|
0.5
|
C5
|
B:THK201
|
3.5
|
72.9
|
0.5
|
CA
|
B:ILE50
|
3.5
|
25.0
|
0.5
|
CB
|
B:ILE50
|
3.7
|
20.7
|
0.5
|
C2
|
B:THK201
|
3.9
|
76.6
|
0.5
|
N
|
A:ILE50
|
4.0
|
27.3
|
0.5
|
C7
|
B:THK201
|
4.0
|
75.4
|
0.5
|
C3
|
B:THK201
|
4.0
|
70.0
|
0.5
|
C7
|
B:THK201
|
4.0
|
75.4
|
0.5
|
O
|
B:GLY49
|
4.0
|
17.4
|
0.5
|
CA
|
A:GLY49
|
4.1
|
33.9
|
0.5
|
N
|
B:GLY49
|
4.1
|
27.7
|
0.5
|
CB
|
A:ILE50
|
4.1
|
24.8
|
0.5
|
C8
|
B:THK201
|
4.3
|
76.2
|
0.5
|
CD1
|
B:ILE50
|
4.3
|
28.2
|
0.5
|
C4
|
B:THK201
|
4.4
|
73.0
|
0.5
|
C2
|
B:THK201
|
4.4
|
76.6
|
0.5
|
C4
|
B:THK201
|
4.5
|
73.0
|
0.5
|
C3
|
B:THK201
|
4.5
|
70.0
|
0.5
|
C8
|
B:THK201
|
4.6
|
76.2
|
0.5
|
C
|
A:GLY49
|
4.7
|
33.8
|
0.5
|
C
|
B:ILE50
|
4.7
|
16.3
|
0.5
|
O
|
B:GLY48
|
4.7
|
45.6
|
1.0
|
CA
|
A:ILE50
|
4.8
|
24.3
|
0.5
|
CG2
|
A:ILE50
|
4.9
|
26.2
|
0.5
|
CG1
|
A:ILE50
|
4.9
|
26.0
|
0.5
|
C
|
B:GLY48
|
4.9
|
39.9
|
1.0
|
O
|
B:ILE50
|
5.0
|
21.4
|
0.5
|
CD1
|
A:ILE50
|
5.0
|
20.7
|
0.5
|
|
Chlorine binding site 3 out
of 4 in 1aid
Go back to
Chlorine Binding Sites List in 1aid
Chlorine binding site 3 out
of 4 in the Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease: Developing A Cycle of Structure-Based Drug Design
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease: Developing A Cycle of Structure-Based Drug Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl201
b:46.3
occ:0.50
|
CL6
|
B:THK201
|
0.0
|
46.3
|
0.5
|
C23
|
B:THK201
|
1.7
|
67.9
|
0.5
|
F18
|
B:THK201
|
2.1
|
75.7
|
0.5
|
C15
|
B:THK201
|
2.7
|
66.5
|
0.5
|
C22
|
B:THK201
|
2.7
|
65.5
|
0.5
|
C24
|
B:THK201
|
2.8
|
72.8
|
0.5
|
C16
|
B:THK201
|
3.1
|
69.5
|
0.5
|
CG2
|
B:ILE54
|
3.5
|
11.9
|
0.5
|
CD1
|
B:ILE47
|
3.6
|
17.3
|
0.5
|
CA
|
B:THR80
|
3.7
|
26.4
|
0.5
|
C14
|
B:THK201
|
3.8
|
65.3
|
0.5
|
CB
|
B:THR80
|
3.8
|
22.1
|
0.5
|
OG1
|
B:THR80
|
3.9
|
27.5
|
0.5
|
N
|
B:THR80
|
4.0
|
32.6
|
0.5
|
C21
|
B:THK201
|
4.0
|
68.2
|
0.5
|
O
|
B:PRO79
|
4.0
|
28.9
|
1.0
|
C25
|
B:THK201
|
4.1
|
69.2
|
0.5
|
CG1
|
B:ILE47
|
4.2
|
34.5
|
0.5
|
C
|
B:PRO79
|
4.2
|
30.4
|
1.0
|
CG1
|
B:VAL56
|
4.2
|
12.0
|
0.5
|
C17
|
B:THK201
|
4.3
|
59.0
|
0.5
|
CB
|
B:ILE54
|
4.3
|
16.9
|
0.5
|
CG1
|
B:VAL32
|
4.3
|
2.7
|
0.5
|
C20
|
B:THK201
|
4.6
|
72.1
|
0.5
|
C13
|
B:THK201
|
4.8
|
64.6
|
0.5
|
CD
|
B:PRO81
|
4.8
|
41.9
|
1.0
|
CD1
|
B:ILE54
|
4.9
|
5.8
|
0.5
|
N
|
B:PRO79
|
4.9
|
18.5
|
1.0
|
CD
|
B:PRO79
|
5.0
|
22.7
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 1aid
Go back to
Chlorine Binding Sites List in 1aid
Chlorine binding site 4 out
of 4 in the Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease: Developing A Cycle of Structure-Based Drug Design
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease: Developing A Cycle of Structure-Based Drug Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl201
b:46.4
occ:0.50
|
CL6
|
B:THK201
|
0.0
|
46.4
|
0.5
|
C23
|
B:THK201
|
1.7
|
67.9
|
0.5
|
F18
|
B:THK201
|
2.1
|
75.7
|
0.5
|
C15
|
B:THK201
|
2.7
|
66.5
|
0.5
|
C22
|
B:THK201
|
2.7
|
65.5
|
0.5
|
C24
|
B:THK201
|
2.8
|
72.8
|
0.5
|
C16
|
B:THK201
|
3.1
|
69.5
|
0.5
|
CA
|
A:THR80
|
3.7
|
14.9
|
0.5
|
CB
|
A:THR80
|
3.7
|
15.6
|
0.5
|
CG2
|
A:ILE54
|
3.7
|
17.6
|
0.5
|
C14
|
B:THK201
|
3.8
|
65.3
|
0.5
|
CD1
|
A:ILE54
|
3.9
|
18.9
|
0.5
|
CD1
|
A:ILE47
|
3.9
|
24.0
|
0.5
|
N
|
A:THR80
|
4.0
|
28.4
|
0.5
|
C21
|
B:THK201
|
4.0
|
68.2
|
0.5
|
O
|
A:PRO79
|
4.0
|
29.0
|
1.0
|
C25
|
B:THK201
|
4.1
|
69.1
|
0.5
|
CG1
|
A:VAL32
|
4.1
|
14.3
|
0.5
|
C
|
A:PRO79
|
4.2
|
30.4
|
1.0
|
CG1
|
A:VAL56
|
4.3
|
4.1
|
0.5
|
C17
|
B:THK201
|
4.3
|
59.0
|
0.5
|
CB
|
A:ILE54
|
4.3
|
13.9
|
0.5
|
OG1
|
A:THR80
|
4.4
|
12.6
|
0.5
|
CG1
|
A:ILE47
|
4.5
|
34.6
|
0.5
|
C20
|
B:THK201
|
4.6
|
72.1
|
0.5
|
CG1
|
A:ILE54
|
4.7
|
19.9
|
0.5
|
C13
|
B:THK201
|
4.8
|
64.7
|
0.5
|
CD
|
A:PRO81
|
4.8
|
41.7
|
1.0
|
CG2
|
A:THR80
|
4.8
|
5.1
|
0.5
|
N
|
A:PRO79
|
4.9
|
18.7
|
1.0
|
CD
|
A:PRO79
|
5.0
|
22.9
|
1.0
|
|
Reference:
E.Rutenber,
E.B.Fauman,
R.J.Keenan,
S.Fong,
P.S.Furth,
P.R.Ortiz De Montellano,
E.Meng,
I.D.Kuntz,
D.L.Decamp,
R.Salto,
J.R.Rosb,
C.S.Craik,
R.M.Stroud.
Structure of A Non-Peptide Inhibitor Complexed with Hiv-1 Protease. Developing A Cycle of Structure-Based Drug Design. J.Biol.Chem. V. 268 15343 1993.
ISSN: ISSN 0021-9258
PubMed: 8340363
Page generated: Fri Jul 19 21:00:56 2024
|